Theriva Biologics TOVX
NYSE TOVX
$0.23 +0.00 (+2.09%)
At close: Aug 21, 2026 · 4:00 PM EDT

Theriva Biologics (TOVX) Tax Rate (2022 - 2023)

Theriva Biologics (TOVX) posted quarterly Tax Rate of 11.58% for Q4 2023, up 83.0% year-over-year from 6.33% in Q4 2022, and down 184.13% quarter-over-quarter from 13.76% in Q3 2023.

Theriva Biologics (TOVX) Tax Rate (2022 - 2023) Analysis & Trends

Theriva Biologics (TOVX) has reported Tax Rate for 2 consecutive years, with 11.58% the latest figure, recorded in Q4 2023.

  • In Q4 2023, Tax Rate rose 83.0% year-over-year to 11.58%; the TTM figure through Dec 2023 stood at 2.66% (up 267.0% YoY), while the FY2025 annual figure was 21.0%, changed 0.0% from the prior year.
  • Tax Rate declined to 11.58% in Q4 2023 per TOVX's latest filing, from 13.76% in the prior quarter.
  • Across five years, Tax Rate topped out at 13.76% in Q3 2023 and bottomed at 12.41% in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 20.98%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 15.11%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 10.91%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -1.96%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 24.15%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 7.49%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 34.12%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.71%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Theriva Biologics 10.64 Mn 10.64 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 -11.58%
Dec 31, 2023 -11.58%
Dec 31, 2023 -11.58%
Sep 30, 2023 13.76%
Sep 30, 2023 13.76%
Sep 30, 2023 13.76%
Jun 30, 2023 6.60%
Jun 30, 2023 6.60%
Jun 30, 2023 6.60%
Mar 31, 2023 6.86%
Mar 31, 2023 6.86%
Mar 31, 2023 6.86%
Dec 31, 2022 -12.41%
Dec 31, 2022 -12.41%
Dec 31, 2022 -12.41%
Sep 30, 2022 6.94%
Sep 30, 2022 6.94%
Sep 30, 2022 6.94%
Jun 30, 2022 10.62%
Jun 30, 2022 10.62%